These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1623640

  • 1. Cardiovascular sensitivity changes to eicosanoids in rats with experimentally induced diabetes mellitus.
    Hodgson WC, Sikorski BW, King RG.
    Clin Exp Pharmacol Physiol; 1992 Jan; 19(1):9-15. PubMed ID: 1623640
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity changes of the perfused hindquarters' vasculature in rats with alloxan-induced diabetes mellitus.
    Boura AL, Hodgson WC, King RG.
    Clin Exp Pharmacol Physiol; 1987 May; 14(5):481-7. PubMed ID: 3677485
    [Abstract] [Full Text] [Related]

  • 3. Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid.
    Boura AL, Hodgson WC, King RG.
    Br J Pharmacol; 1986 Nov; 89(3):613-8. PubMed ID: 3099877
    [Abstract] [Full Text] [Related]

  • 4. Thromboxane A2 receptor stimulation similarly potentiates pressor responses to 5-hydroxytryptamine in perfused hindquarters of non-diabetic and alloxan diabetic rats.
    Sikorski BW, Hodgson WC, King RG.
    Clin Exp Pharmacol Physiol; 1991 Apr; 18(4):237-44. PubMed ID: 1829992
    [Abstract] [Full Text] [Related]

  • 5. Augmented potentiation of renal vasoconstrictor responses by thromboxane A2 receptor stimulation in the alloxan-diabetic rat.
    Hodgson WC, King RG, Boura AL.
    J Pharm Pharmacol; 1990 Jun; 42(6):423-7. PubMed ID: 1979623
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in reactivity towards 5-hydroxytryptamine in the renal vasculature of the diabetic spontaneously hypertensive rat.
    Boston PC, Hodgson WC.
    J Hypertens; 1997 Jul; 15(7):769-74. PubMed ID: 9222945
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms of coronary vasoconstriction induced by Na arachidonate in experimentally diabetic dogs.
    Sterin-Borda L, Borda E, del Castillo EJ, Gimeno MF, Gimeno AL.
    Experientia; 1982 Jul 15; 38(7):835-7. PubMed ID: 6809489
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disturbed lipid metabolism in diabetic coronary vessels.
    Koltai MZ, Rösen P, Hadházy P, Aranyi Z, Ballagi-Pordány G, Pogátsa G.
    Mol Cell Biochem; 1992 Feb 12; 109(2):189-96. PubMed ID: 1320734
    [Abstract] [Full Text] [Related]

  • 19. Involvement of thromboxane and leukotriene in arachidonate induced coronary constriction in diabetic rats.
    Takiguchi Y, Umemura K, Hashimoto H, Nakashima M.
    Diabetologia; 1989 Jun 12; 32(6):337-41. PubMed ID: 2503411
    [Abstract] [Full Text] [Related]

  • 20. Alterations of vascular prostacyclin and thromboxane A2 in Dahl genetical strain susceptible to salt-induced hypertension.
    Uehara Y, Tobian L, Iwai J, Ishii M, Sugimoto T.
    Prostaglandins; 1987 May 12; 33(5):727-38. PubMed ID: 3108964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.